Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain

NCT04809376 is registered in ClinicalTrials.gov with Paradigm Biopharmaceuticals USA (INC) as lead sponsor.

NCT NCT04809376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04809376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain
Lead sponsor
Paradigm Biopharmaceuticals USA (INC)
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
October 19, 2021
Completion date
January 6, 2025
Enrollment
602 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee